Melinta Therapeutics, Inc.
(NASDAQ : MLNT)

( )
MLNT PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
ICPTIntercept Pharmaceuticals, Inc.
-1.40%111.9718.6%$193.32m
AMRNAmarin Corporation Plc Sponsored ADR
-2.28%18.862.0%$168.81m
JAZZJazz Pharmaceuticals Plc
0.82%135.552.3%$105.93m
GWPHGW Pharmaceuticals PLC Sponsored ADR
-0.30%168.116.3%$90.85m
HZNPHorizon Pharma plc
1.99%28.217.3%$90.33m
SAGESAGE Therapeutics, Inc.
-0.50%156.108.8%$86.68m
PRGOPerrigo Co. Plc
1.09%49.206.8%$70.71m
ICLRICON Plc
0.81%134.974.1%$58.38m
MNKMallinckrodt Plc
2.07%23.1821.0%$54.40m
UTHRUnited Therapeutics Corporation
-0.17%118.6514.3%$51.73m
PTLAPortola Pharmaceuticals, Inc.
1.12%33.427.6%$47.10m
AERIAerie Pharmaceuticals, Inc.
-3.08%45.646.9%$38.56m
ENDPEndo International Plc
2.10%8.778.9%$37.38m
MYOKMyoKardia, Inc.
0.87%54.332.4%$37.25m
CTLTCatalent Inc
0.19%42.652.4%$28.95m

Company Profile

Melinta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the discover, development and commercialization of antibiotics. Its product, Baxbela, is used in the treatment of acute bacterial skin and skin structure infections. The company was founded by William L. Jorgensen, Peter Moore, and Thomas A. Steitz in October 2000 is headquartered in New Haven, CT.